MiR-1539 and Its Potential Role as a Novel Biomarker for Colorectal Cancer.

Cui, Xueyang; Lv, Zhi; Ding, Hanxi; Xing, Chengzhong; Yuan, Yuan

Cui, Xueyang; Lv, Zhi; Ding, Hanxi; Xing, Chengzhong; Yuan, Yuan.

Afiliación

Cui X; Tumor Etiology and Screening Department of Cancer Institute and General Surgery, The First Hospital of China Medical University, Shenyang, China.
Lv Z; Key Laboratory of Cancer Etiology and Prevention in Liaoning Education Department, The First Hospital of China Medical University, Shenyang, China.
Ding H; Key Laboratory of GI Cancer Etiology and Prevention in Liaoning Province, The First Hospital of China Medical University, Shenyang, China.
Xing C; Tumor Etiology and Screening Department of Cancer Institute and General Surgery, The First Hospital of China Medical University, Shenyang, China.
Yuan Y; Key Laboratory of Cancer Etiology and Prevention in Liaoning Education Department, The First Hospital of China Medical University, Shenyang, China.

Front Oncol ; 10: 531244, 2020.

Article en En | MEDLINE | ID: mdl-33680906

Palabras clave

biomarker; colorectal cancer; exosome; miR-1539; serum; tissue

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google